Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies

References

• Reardon DA, Rich JN, Friedman HS, Bigner DD. Recent advances in the treatment of malignant astrocytoma. J.- Clin. Oncol.24(8), 1253–1265 (2006).
   PubMed Web of Science ®Google Scholar
• Ohgaki H, Dessen P, Jourde B et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res.64(19), 6892–6899 (2004).
   PubMed Web of Science ®Google Scholar
• Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer71(8), 2585–2597 (1993).
   PubMed Web of Science ®Google Scholar
• Gaspar LE, Fisher BJ, Macdonald DR et al. Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int. J. Radiat. Oncol. Biol. Phys.24(1), 55–57 (1992).
   PubMed Web of Science ®Google Scholar
• Walker MD, Alexander E Jr, Hunt WE et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J. Neurosurg.49(3), 333–343 (1978).
   PubMed Web of Science ®Google Scholar
• Sandberg-Wollheim M, Malmstrom P, Stromblad LG et al. A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer68(1), 22–29 (1991).
   PubMed Web of Science ®Google Scholar
• Brem H, Mahaley MS Jr, Vick NA et al. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J. Neurosurg.74(3), 441–446 (1991).
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med.352(10), 987–996 (2005).
   PubMed Web of Science ®Google Scholar
• LohaniS, O’Driscoll BR, Woodcock AA. 25-year study of lung fibrosis following carmustine therapy for brain tumor in childhood. Chest126(3), 1007 (2004).
   PubMed Web of Science ®Google Scholar
• Shen YC, Chiu CF, Chow KC, Chen CL, Liaw YC, Yeh SP. Fatal pulmonary fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-β1 and cyclooxygenase-2. Bone Marrow Transplant.34(7), 609–614 (2004).
   PubMed Web of Science ®Google Scholar
• Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet359(9311), 1011–1018 (2002).
   PubMed Web of Science ®Google Scholar
• Dang W, Daviau T, Brem H. Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy. Pharm. Res.13(5), 683–691 (1996).
   PubMed Web of Science ®Google Scholar
• Able CM, Mills MD, McNeese MD, Hogstrom KR. Evaluation of a total scalp electron irradiation technique. Int. J. Radiat. Oncol. Biol. Phys.21(4), 1063–1072 (1991).
   Google Scholar
• Fleming AB, Saltzman WM. Pharmacokinetics of the carmustine implant. Clin. Pharmacokinet.41(6), 403–419 (2002).
   PubMed Web of Science ®Google Scholar
• Domb AJ, Rock M, Perkin C, Yipchuck G, Broxup B, Villemure JG. Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain. Biomaterials16(14), 1069–1072 (1995).
   Google Scholar
• Grossman SA, Reinhard C, Colvin OM et al. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. J. Neurosurg.76(4), 640–647 (1992).
   PubMed Web of Science ®Google Scholar
• Fung LK, Shin M, Tyler B, Brem H, Saltzman WM. Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain. Pharm. Res.13(5), 671–682 (1996).
   PubMed Web of Science ®Google Scholar
• Fung LK, Ewend MG, Sills A et al. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclo phosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res.58(4), 672–684 (1998).
   PubMed Web of Science ®Google Scholar
• Tamargo RJ, Myseros JS, Epstein JI, Yang MB, Chasin M, Brem H. Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. Cancer Res.53(2), 329–333 (1993).
   PubMed Web of Science ®Google Scholar
• Buahin KG, Brem H. Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release. J. Neurooncol.26(2), 103–110 (1995).
   PubMed Web of Science ®Google Scholar
• Brem H, Piantadosi S, Burger PC et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group.Lancet345(8956), 1008–1012 (1995).
   PubMed Web of Science ®Google Scholar
• Brem H, Ewend MG, Piantadosi S, Greenhoot J, Burger PC, Sisti M. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase I trial. J. Neurooncol.26(2), 111–123 (1995).
   PubMed Web of Science ®Google Scholar
• Valtonen S, Timonen U, Toivanen P et al. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery41(1), 44–48; discussion 48–49 (1997).
   PubMed Web of Science ®Google Scholar
• Westphal M, Hilt DC, Bortey E et al. A Phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro. Oncol.5(2), 79–88 (2003).
   PubMed Web of Science ®Google Scholar
• Westphal M, Ram Z, Riddle V, Hilt D, Bortey E; Executive Committee of the Gliadel Study Group. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir. (Wien).148(3), 269–275; discussion 275 (2006).
   PubMed Web of Science ®Google Scholar
• Mutter N, Stupp R. Temozolomide: a milestone in neuro-oncology and beyond?Expert Rev. Anticancer Ther.6(8), 1187–1204 (2006).
   PubMed Web of Science ®Google Scholar
• Hegi ME, Diserens AC, Gorlia T et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med.352(10), 997–1003 (2005).
   PubMed Web of Science ®Google Scholar
• Tamargo RJ, Epstein JI, Reinhard CS, Chasin M, Brem H. Brain biocompatibility of a biodegradable, controlled-release polymer in rats. J. Biomed. Mater. Res.23(2), 253–266 (1989).
   PubMed Web of Science ®Google Scholar
• Brem H, Tamargo RJ, Olivi A et al. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. J. Neurosurg.80(2), 283–290 (1994).
   PubMed Web of Science ®Google Scholar
• Kleinberg LR, Weingart J, Burger P et al. Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management. Cancer Invest.22(1), 1–9 (2004).
   PubMed Web of Science ®Google Scholar
• Engelhard HH. Tumor bed cyst formation after BCNU wafer implantation: report of two cases. Surg. Neurol.53(3), 220–224 (2000).
   PubMedGoogle Scholar
• McGirt MJ, Villavicencio AT, Bulsara KR, Friedman HS, Friedman AH. Management of tumor bed cysts after chemotherapeutic wafer implantation. Report of four cases. J. Neurosurg.96(5), 941–945 (2002).
   Google Scholar
• Lawson HC, Sampath P, Bohan E et al. Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience. J. Neurooncol.83(1), 61–70 (2007).
   PubMed Web of Science ®Google Scholar
• Kaal EC, Vecht CJ. The management of brain edema in brain tumors. Curr. Opin. Oncol.16, 593–600 (2004).
   PubMed Web of Science ®Google Scholar
• Sipos EP, Tyler B, Piantadosi S, Burger PC, Brem H. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Cancer Chemother. Pharmacol.39, 383–389 (1997).
   PubMed Web of Science ®Google Scholar
• Olivi A, Grossman SA, Tatter S et al. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial. J. Clin. Oncol.21(9), 1845–1849 (2003).
   PubMed Web of Science ®Google Scholar
• Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J. Clin.49(1), 8–31 (1999).
   PubMed Web of Science ®Google Scholar
• Patchell RA, Tibbs PA, Walsh JW et al. A randomized trial of surgery in the treatment of single metastases to the brain. N. Engl. J. Med.322(8), 494–500 (1990).
   PubMed Web of Science ®Google Scholar
• Patchell RA, Tibbs PA, Regine WF et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA280(17), 1485–1489 (1998).
   PubMed Web of Science ®Google Scholar
• Ewend MG, Williams JA, Tabassi K et al. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models. Cancer Res.56(22), 5217–5223 (1996).
   PubMed Web of Science ®Google Scholar
• Ewend MG, Sampath P, Williams JA, Tyler BM, Brem H. Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast carcinoma. Neurosurgery43(5), 1185–1193 (1998).
   PubMed Web of Science ®Google Scholar
• Ewend MG, Brem S, Gilbert M et al. Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control. Clin. Cancer Res.13(12), 3637–3641 (2007).
   PubMed Web of Science ®Google Scholar
• Laws ER Jr, Morris AM, Maartens N. Gliadel for pituitary adenomas and craniopharyngiomas. Neurosurgery53(2), 255–269; discussion 259–260 (2003).
   Google Scholar
• Park MC, Weaver CE Jr, Donahue JE, Sampath P. Intracavitary chemotherapy (Gliadel) for recurrent esthesioneuroblastoma: case report and review of the literature. J. Neurooncol.77(1), 47–51 (2006).
   PubMed Web of Science ®Google Scholar
• Plowman J, Waud WR, Koutsoukos AD, Rubinstein LV, Moore TD, Grever MR. Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res.54(14), 3793–3799 (1994).
   PubMed Web of Science ®Google Scholar
• Mitchell RB, Dolan ME. Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumor cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemother. Pharmacol.32(1), 59–63 (1993).
   PubMedGoogle Scholar
• Kaina B, Christmann M, Naumann S, Roos WP. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair6(8), 1079–1099 (2007).
   PubMed Web of Science ®Google Scholar
• Gururangan S, Cokgor L, Rich JN et al. Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. Neuro. Oncol.3(4), 246–250 (2001).
   PubMed Web of Science ®Google Scholar
• Heery CR, Desjardins A, Quinn JA et al. Acute toxicity analysis of patients receiving surgery, Gliadel wafer implantation, and postoperative daily temozolomide with radiation therapy for primary high-grade glioma. Proc. Am. Soc. Clin. Oncol.24Suppl. 18), 11504 (2006).
   Google Scholar
• AsherAL. Prospective analysis of temozolomide as adjuvant to Gliadel and radiation in newly diagnosed malignant glioma. Proc. Am. Assoc. Neurol. Surg.14,42860 (2007).
   Google Scholar
• La RoccaRV, Hodes J, Villanueva WG et al. A Phase II study of radiation with concomitant and then sequential temozolomide (TMZ) in patients with newly diagnosed supratentorial high-grade malignant glioma who have undergone surgery with carmustine (BCNU) wafer insertion. Proceedings of the 11th Scientific Meeting of the Society for Neuro-Oncology. Orlando, Florida, USA, 16–19 November, 2006 (Abstract TA-28).
   Google Scholar
• Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N. Engl. J. Med.343, 1350–1354 (2000).
   PubMed Web of Science ®Google Scholar
• Dolan ME, Moschel RC, Pegg AE. Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl Acad. Sci. USA87, 5368–5372 (1990).
   PubMed Web of Science ®Google Scholar
• Rabik CA, Njoku MC, Dolan ME. Inactivation of O6-alkylguanine DNA alkyltransferase as a means to enhance chemotherapy. Cancer Treat. Rev.32, 261–276 (2006).
   PubMed Web of Science ®Google Scholar
• Rhines LD, P. Sampath, Dolan ME, Tyler BM, Brem H, Weingart J. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma. Cancer Res.60, 6307–6310 (2000).
   Google Scholar
• Weingart J, Grossman SA, Carson KA et al. Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial. J. Clin. Oncol.25, 399–404 (2007).
   PubMed Web of Science ®Google Scholar
• Thompson RC, Pardoll DM, Jaffee EM et al. Systemic and local paracrine cytokine therapies using transduced tumor cells are synergistic in treating intracranial tumors. J. Immunother. Emphasis Tumor Immunol.19, 405–413 (1996).
   PubMed Web of Science ®Google Scholar
• Ewend MG, Thompson RC, Anderson R et al. Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous system. J. Immunother.23, 438–448 (2000).
   PubMed Web of Science ®Google Scholar
• Sampath P, Hanes J, DiMeco F et al. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors. Cancer Res.59, 2107–2114 (1999).
   PubMed Web of Science ®Google Scholar
• Raza SM, Pradilla G, Legnani FG et al. Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours. Expert Opin. Biol. Ther.5, 477–494 (2005).
   PubMed Web of Science ®Google Scholar
• Yuan X, Tabassi K, Williams JA. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma. Radiat. Oncol. Investig.7, 218–230 (1999).
   PubMedGoogle Scholar
• Williams JA, Dillehay LE, Tabassi K, Sipos E, Fahlman C, Brem H. Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma. J. Neurooncol.32, 181–192 (1997).
   PubMedGoogle Scholar
• Doiron A, Yapp DT, Olivares M, Zhu JX, Lehnert S. Tumor radiosensitization by sustained intratumoral release of bromodeoxyuridine. Cancer Res.59, 3677–3681 (1999).
   PubMed Web of Science ®Google Scholar
• Li Y, Owusu A, Lehnert S. Treatment of intracranial rat glioma model with implant of radiosensitizer and biomodulator drug combined with external beam radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.58, 519–527 (2004).
   PubMed Web of Science ®Google Scholar
• Lesniak MS, Upadhyay U, Goodwin R, Tyler B, Brem H. Local delivery of doxorubicin for the treatment of malignant brain tumors in rats. Anticancer Res.25, 3825–3831 (2005).
   PubMed Web of Science ®Google Scholar
• Pradilla G, Legnani FG, Petrangolini G et al. Local delivery of a synthetic endostatin fragment for the treatment of experimental gliomas. Neurosurgery57, 1032–1040; discussion 1032–1040 (2005).
   PubMed Web of Science ®Google Scholar
• Yapp DT, Lloyd DK, Zhu J, Lehnert S. Radiosensitization of a mouse tumor model by sustained intra-tumoral release of etanidazole and tirapazamine using a biodegradable polymer implant device. Radiother. Oncol.53, 77–84 (1999).
   PubMed Web of Science ®Google Scholar
• Weingart JD, Thompson RC, Tyler B, Colvin OM, Brem H. Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model. Int. J. Cancer62, 605–609 (1995).
   PubMed Web of Science ®Google Scholar
• Olivi A, Ewend MG, Utsuki T et al. Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat. Cancer Chemother. Pharmacol.39, 90–96 (1996).
   PubMed Web of Science ®Google Scholar
• Sheleg SV, Korotkevich EA, Zhavrid EA, Muravskaya GV, Smeyanovich AF, Shanko YG. Local chemotherapy with cisplatin-depot for glioblastoma multiforme. J. Neurooncol.60, 53–59 (2002).
   PubMed Web of Science ®Google Scholar
• Judy KD, Olivi A, Buahin KG et al. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. J. Neurosurg.82, 481–486 (1995).
   Google Scholar
• Legnani FG, Pradilla G, Thai QA et al. Lactacystin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers. J. Neurooncol.77, 225–232 (2006).
   PubMed Web of Science ®Google Scholar
• Weingart JD, Sipos EP, Brem H. The role of minocycline in the treatment of intracranial 9L glioma. J. Neurosurg.82, 635–640 (1995).
   PubMed Web of Science ®Google Scholar
• DiMeco F, Li KW, Tyler BM, Wolf AS, Brem H, Olivi A. Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats. J. Neurosurg.97, 1173–1178 (2002).
   PubMed Web of Science ®Google Scholar
• Sampath P, Rhines LD, DiMeco F, Tyler BM, Park MC, Brem H. Interstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma. J. Neurooncol.80, 9–17 (2006).
   Google Scholar
• Brem S, Tyler B, Li K et al. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Cancer Chemother. Pharmacol.60, 643–650 (2007).
   PubMed Web of Science ®Google Scholar
• Fournier E, Passirani C, Vonarbourg A et al. Therapeutic efficacy study of novel 5-FU-loaded PMM 2.1.2-based microspheres on C6 glioma. Int J Pharm.268, 31–35 (2003).
   Google Scholar
• Lesniak SM, Brem H. Targeted therapy for brain tumours. Nat. Rev. Drug Discov.3(6), 499–508 (2004).
   PubMed Web of Science ®Google Scholar